Literature DB >> 1752083

Active components of intestinal bacteria for abdominal irradiation-induced inhibition of lung metastases.

T Jibu1, K Ando, T Matsumoto, S Koike, O Kobori, Y Morioka, S Kanegasaki.   

Abstract

We have previously reported that abdominal irradiation of mice inhibited lung metastases of a weakly immunogenic fibrosarcoma, and that transmigration after the irradiation of Enterobacter cloacae into mesenteric lymph nodes coincided with this phenomenon. In this paper, we show that Escherichia coli as well as E. cloacae reduce the number of metastatic lung colonies when these bacteria were intravenously injected into mice prior to the tumour cell challenge. The inhibition was caused not only by the administration of living bacteria but also by that of killed bacteria. Bacterial lipopolysaccharide (LPS), a component of membrane, replaced at least in part the effect of whole bacteria. Transfer of spleen cells from LPS-treated mice into intact recipients prominently inhibited metastatic development in the recipient mice. 'Cross transfer' between LPS high responders and LPS low responders suggested an indirect activity of transferred spleen cells. The antimetastatic activity of LPS depended on the tumour cell type; metastasis of fibrosarcomas was extensively inhibited by LPS irrespective of tumour immunogenicity while that of adenocarcinomas was only slightly inhibited. These results suggest that non-immunological mechanisms are involved in the antimetastatic activity of LPS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752083     DOI: 10.1007/bf01768581

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  29 in total

1.  The nature of intestinal radiation death.

Authors:  H QUASTLER
Journal:  Radiat Res       Date:  1956-04       Impact factor: 2.841

2.  Relation of the indigenous flora of the small intestine of the rat to post-irradiation bacteremia.

Authors:  J G VINCENT; R C VEOMETT; R F RILEY
Journal:  J Bacteriol       Date:  1955-01       Impact factor: 3.490

3.  Inhibition of tumor growth by the peptidoglycan from Bacillus megaterium.

Authors:  C Nauciel; A F Goguel
Journal:  J Natl Cancer Inst       Date:  1977-12       Impact factor: 13.506

Review 4.  The role of natural killer cells in the control of tumor growth and metastasis.

Authors:  N Hanna
Journal:  Biochim Biophys Acta       Date:  1985

5.  Morphologic response of the mucosa of human small intestine to x-ray exposure.

Authors:  J S Trier; T H Browning
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

6.  Studies of intestinal microflora. VI. Effect of x irradiation on the fecal microflora of the rat.

Authors:  A S Klainer; S Gorbach; L Weinstein
Journal:  J Bacteriol       Date:  1967-08       Impact factor: 3.490

7.  Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.

Authors:  I J Fidler; S Sone; W E Fogler; Z L Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

9.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

Authors:  T Tokunaga; H Yamamoto; S Shimada; H Abe; T Fukuda; Y Fujisawa; Y Furutani; O Yano; T Kataoka; T Sudo
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

10.  Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens.

Authors:  J R McGhee; J J Farrar; S M Michalek; S E Mergenhagen; D L Rosenstreich
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The potential roles of bacteria to improve radiation treatment outcome.

Authors:  E Kouhsari; A Ghadimi-Daresajini; H Abdollahi; N Amirmozafari; S R Mahdavi; S Abbasian; S H Mousavi; H F Yaseri; M Moghaderi
Journal:  Clin Transl Oncol       Date:  2017-06-16       Impact factor: 3.405

2.  Antimetastatic activity of lipopolysaccharide against a NK-resistant murine fibrosarcoma.

Authors:  T Jibu; S Koike; K Ando; T Matsumoto; M Kimoto; S Kanegasaki
Journal:  Clin Exp Metastasis       Date:  1993-07       Impact factor: 5.150

3.  Significance of platelets in an antimetastatic activity of bacterial lipopolysaccharide.

Authors:  M Kimoto; K Ando; S Koike; T Matsumoto; T Jibu; H Moriya; S Kanegasaki
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.